Skip to main content

Table 1 Psychometric data of the study population

From: Psychological distress of patients suffering from restless legs syndrome: a cross-sectional study

 

Untreated patients

(N = 69)

Treated patients

  

Satisfied with the actual treatment

(N = 35)

Dissatisfied with the actual treatment

   

Augmentation (N = 19)

Loss of efficacy

(N = 35)

Side effects

(N = 8)

IRLS

24.0 (8.8)

26.9 (5.6)

31.4 (4.1)**

31.6 (5.9)***

27.1 (5.8)

BDI-II

11.3 (8.9)

12.0 (8.4)

15.8 (8.3)*

16.1 (10.3)*

11.9 (5.4)

SCL-90-R

   GSI

0.7 (0.6)

0.7 (0.5)

1.0 (0.6)*

0.9 (0.6)

0.6 (0.3)

   Somatisation

0.9 (0.6)

0.9 (0.6)

1.2 (0.6)*

1.2 (1.1)

0.8 (0.4)

   Compulsivity

0.8 (0.7)

0.8 (0.8)

1.2 (0.8)*

1.2 (0.9)*

0.9 (0.4)

   Insecurity in social contact

0.8 (2.7)

0.6 (0.6)

0.9 (0.6)*

06. (0.6)

0.5 (0.5)

   Depression

0.7 (0.8)

0.8 (0.8)

1.0 (0.8)

1.0 (0.8)*

0.8 (0.4)

   Anxiety

0.6 (0.1)

0.7 (0.5)

0.9 (0.6)*

0.8 (0.6)

0.4 (0.3)

   Hostility

0.4 (0.5)

0.5 (0.5)

0.8 (0.6)**

0.6 (0.7)

0.4 (0.3)

   Phobic anxiety

0.4 (0.6)

0.2 (0.4)

0.5 (0.7)

0.5 (0.6)*

0.2 (0.2)

   Paranoid ideation

0.4 (0.5)

0.4 (0.5)

0.8 (0.7)**

0.6 (0.6)

0.3 (0.2)

   Psychoticism

0.4 (0.7)

0.3 (0.7)

0.6 (1.0)

0.4 (0.5)

0.2 (0.2)

  1. *: p < 0.05; **: p < 0.01; ***: p < 0.001
  2. Raw scores of sub-scales and Global Severity Index (GSI) of the SCL-90-R are presented. Values are mean (SD). Statistically significant results refer to comparisons of each group with untreated patients.